BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7685206)

  • 1. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential.
    Muench MO; Firpo MT; Moore MA
    Blood; 1993 Jun; 81(12):3463-73. PubMed ID: 7685206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors.
    Muench MO; Moore MA
    Exp Hematol; 1992 Jun; 20(5):611-8. PubMed ID: 1587307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
    Muench MO; Schneider JG; Moore MA
    Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK-2 ligand and KIT ligand.
    Yonemura Y; Ku H; Lyman SD; Ogawa M
    Blood; 1997 Mar; 89(6):1915-21. PubMed ID: 9058711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
    Varas F; Bernard A; Bueren JA
    Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cells found in lineage-positive subsets in the bone marrow of 5-fluorouracil-treated mice.
    Nishi N; Osawa M; Ishikawa R; Nishikawa M; Tsumura H; Inoue H; Sudo T
    Stem Cells; 1995 Sep; 13(5):517-23. PubMed ID: 8528101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials.
    Yang QE; Fong SE; Li K; Gonda MA; Tobin GJ
    Med Sci Monit; 2005 Jun; 11(6):BR154-161. PubMed ID: 15917709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated and long-term hematopoietic engraftment in mice transplanted with ex vivo expanded bone marrow.
    Serrano F; Varas F; Bernad A; Bueren JA
    Bone Marrow Transplant; 1994 Dec; 14(6):855-62. PubMed ID: 7711665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells.
    Szilvassy SJ; Weller KP; Chen B; Juttner CA; Tsukamoto A; Hoffman R
    Blood; 1996 Nov; 88(9):3642-53. PubMed ID: 8896435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Earlier hematopoietic reconstitution by mouse cord blood transplantation combined with bone marrow c-kit(+) hematopoietic progenitor cells].
    Yuan YH; Li J; Yu YH; Shi J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):416-21. PubMed ID: 21518499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells.
    Okada S; Nakauchi H; Nagayoshi K; Nishikawa S; Miura Y; Suda T
    Blood; 1992 Dec; 80(12):3044-50. PubMed ID: 1281687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo.
    Quesniaux VF; Wehrli S; Steiner C; Joergensen J; Schuurman HJ; Herrman P; Schreier MH; Schuler W
    Blood; 1994 Sep; 84(5):1543-52. PubMed ID: 7520778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of stem cell factor and interleukin 6 or interleukin 11 on the expansion of murine hematopoietic progenitors in liquid suspension culture.
    Ariyama Y; Misawa S; Sonoda Y
    Stem Cells; 1995 Jul; 13(4):404-13. PubMed ID: 7549899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.
    Kedar E; Tsuberi BZ; Landesberg A; Anafi M; Leshem B; Gillis S; Urdal DL; Slavin S
    Bone Marrow Transplant; 1988 Jul; 3(4):297-314. PubMed ID: 3048495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by Ex vivo expansion.
    Szilvassy SJ; Bass MJ; Van Zant G; Grimes B
    Blood; 1999 Mar; 93(5):1557-66. PubMed ID: 10029584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential.
    Traycoff CM; Cornetta K; Yoder MC; Davidson A; Srour EF
    Exp Hematol; 1996 Feb; 24(2):299-306. PubMed ID: 8641356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
    Shatry AM; Jones M; Levy RB
    Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
    Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
    Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.